Delivery Order SPE2DB20D3101-SPE2DB25FRQA9
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 7, 2025, for the supply of Clobazam 10 mg tablets (100-count packaging) with a ceiling value of $2,002.00. The contract employs firm fixed-price pricing and is scheduled for ultimate completion by May 8, 2025. This award represents a child delivery order issued under a larger contract vehicle, reflecting the DLA's...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract, valued at $1,567.49, is for the provision of clobazam 10 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,180.96 delivery order for 100 tablets of Clobazam 10 mg, with an ultimate completion date of August 1, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count) valued at $1,555.93 under a firm fixed price contract. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1.84K to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) with a completion date of July 1, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99M global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,390.75 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100-count units) on August 26, 2025, with completion scheduled for August 27, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and identifies Conshohocken, Pennsylvania as the place of performance, which notably aligns with AmerisourceBergen's corporate headquarters location. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $3,143.34 to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery falls...
- This delivery order, awarded July 23, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 100 tablets of Clobazam 10 mg at a ceiling value of $6,303.15. The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the contractor's capability to...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,618,636 units of Clobazam 10 mg tablets in 100-count packages. The $3,111.86 contract has a completion date of February 12, 2024. AmerisourceBergen Drug Corp, which serves as a prime contractor for the DLA Troop Support Medical program, has previously been awarded indefinite delivery contracts (IDCs) by...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Clobazam 10 mg tablets (100-count units) with a ceiling value of $1,555.93. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by May 7, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRQA9Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,552.54 by the Defense Logistics Agency (DLA) on July 14, 2025, with an ultimate completion date of July 15, 2025. The contract calls for the delivery of Clobazam 10 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Clobazam is a benzodiazepine medication primarily used for seizure management and is part of the Defense Health Agency's pharmaceutical supply chain supporting military medical facilities. The delivery order fulfills immediate pharmaceutical procurement needs through AmerisourceBergen's established prime vendor relationship with the DLA, which enables the company to supply a comprehensive range of medications and medical supplies to support military healthcare programs globally. The company's federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements across diverse pharmaceutical therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.6k | 7/14/25 |